Pharma Firm Eyes Marijuana Imports Under DEA Watch
Published Date: 4/17/2026
Notice
Summary
Royal Emerald Pharmaceuticals wants to become an official importer of certain controlled substances like marijuana and its extracts. People and companies involved with these drugs can share their thoughts or ask for a hearing by May 18, 2026. This move could affect how these substances are brought into the U.S., with no immediate cost changes announced.
Free Policy Watch
New rules are filed every week. Most people never see them.
Pick a topic. PRIA watches every federal rule and tells you when one hits your household.
Pick a topic to get started
No Economic Impacts Identified for this Document
Your PRIA Score
Personalized for You
How does this regulation affect your finances?
Sign up for a PRIA Policy Scan to see your personalized alignment score for this federal register document and every other regulation we track. We analyze your financial profile against policy provisions to show you exactly what matters to your wallet.
Key Dates
Department and Agencies
Take It Personal
Get Your Personalized Policy View
Start a Free Government Policy Watch to see how policy affects your household, then upgrade to PRIA Full Coverage for year-round monitoring.
Already have an account? Sign in